文献速递创伤与烧伤复苏、休克与脓毒症

哥伦比亚经验:一级创伤中心REBOA从大口径到低profile装置的进展

The Colombian Experience in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): The Progression From a Large Caliber to a Low-Profile Device at a Level I Trauma Center.
PubMed 文献 · Shock · 2021-01-01
一句话结论单中心前瞻性观察显示,7 Fr鞘管REBOA相关腹股沟并发症低于11 Fr鞘管(0% vs 22%,P=0.05),作者建议优先选用7 Fr。

该单中心前瞻性观察研究纳入50例接受REBOA的创伤患者,记录入院参数、并发症和临床结局。多数导管在手术室置入(47例,94%),动脉入路采用外科切开(40例,80%)。所有并发症均与36例患者使用的11 Fr鞘管导管相关(8/36,22% vs 0/14,0%;P=0.05)。作者结论认为REBOA可安全用于钝性或穿透性胸部、腹部和骨盆创伤,7 Fr鞘管置入与更低并发症相关,应优先于更大口径。

要点

  • 50例创伤患者接受REBOA,47例(94%)在手术室置入,40例(80%)经外科切开建立动脉入路。
  • 所有并发症均与11 Fr鞘管导管相关:使用11 Fr鞘管的36例中8例(22%)出现并发症,使用7 Fr鞘管的14例中0例(0%),P=0.05。
  • 作者结论认为REBOA可安全用于钝性或穿透性胸部、腹部和骨盆创伤。
  • 作者建议7 Fr鞘管应优先于更大口径使用,因其与更低并发症相关。

适用人群与场景

  • 接受REBOA的创伤患者,包括钝性或穿透性胸部、腹部和骨盆创伤。

处置流程与药物剂量

  • REBOA导管置入:47例(94%)在手术室进行,动脉入路采用外科切开40例(80%)。
  • 装置选择:作者建议优先使用7 Fr鞘管而非更大口径,因7 Fr鞘管与更低并发症相关(0/14 vs 8/36,P=0.05)。

研究设计与关键结果

  • 研究类型:前瞻性、观察性、单中心研究;样本量50例创伤患者。
  • 主要结局:所有并发症均与11 Fr鞘管导管相关,使用11 Fr鞘管的36例中8例(22%)出现并发症,使用7 Fr鞘管的14例中0例(0%),P=0.05。
  • 操作特征:REBOA导管置入47例(94%)在手术室,动脉入路外科切开40例(80%)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性单中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为REBOA可安全用于钝性或穿透性胸部、腹部和骨盆创伤。
  • 作者建议7 Fr鞘管应优先于更大口径使用,因与更低腹股沟并发症相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is now performed in many trauma centers, it is used at more than 250 hospitals in the United States and there is an increase rate of publications with the experience in these centers, but there is a gap of knowledge regarding the use of REBOA in Latin-America. This paper endeavors to describe the utilization of REBOA at a high level Latin-American Trauma Center and the transition from a large caliber to a low-profile device with the concomitant reduction in the groin access complications.

METHODS: A prospective, observational, single-center study was conducted. We included all trauma patients who underwent REBOA. We recorded data from admission parameters, complications, and clinical outcomes.

RESULTS: Fifty patients were included. Most of the REBOA catheters were inserted in the operating room [47 (94%)], and the arterial access was done by surgical cutdown [40 (80%)]. All the complications were associated with the catheter of 11 Fr Sheath used in 36 patients [n = 8/36 (22%) vs. n = 0/14 (0%); P = 0.05].

CONCLUSION: REBOA can be used safely in blunt or penetrating thoracic, abdominal, and pelvic trauma. The insertion of a 7 Fr Sheath was associated with lower complications, so its use should be preferred over larger calibers.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ordoñz CA, Khan M, Cotton B, et al. The Colombian Experience in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): The Progression From a Large Caliber to a Low-Profile Device at a Level I Trauma Center. Shock. 2021. PMID: 31977958. doi:10.1097/SHK.0000000000001515

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。